The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development

Journal of Immunology

Volumn 192, Issue 6, 2014, Pages 2677-2688

  Crotta, Stefania ^a   Gkioka, Annita ^a   Male, Victoria ^b   Duarte, João H ^a   Davidson, Sophia ^a   Nisoli, Ilaria ^b   Brady, Hugh J M ^b   Wack, Andreas ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EOMESODERMIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; PROTEIN E4BP4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CELL POPULATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; LIVER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; INTERLEUKIN-7; KILLER CELLS, NATURAL; LIVER; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SPLEEN; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES; THYMUS GLAND;

EID: 84897505650     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302765     Document Type: Article

References (45)

1. Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8: 259-268.
2. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
3. Lee, S. H., and C. A. Biron. 2010. Here today-not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections. Eur. J. Immunol. 40: 923-932.
4. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
5. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
6. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
7. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
8. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
9. DiSanto, J. P. 1997. Cytokines: shared receptors, distinct functions. Curr. Biol. 7: R424-R426.
10. Suzuki, H., G. S. Duncan, H. Takimoto, and T. W. Mak. 1997. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J. Exp. Med. 185: 499-505.
11. Rosmaraki, E. E., I. Douagi, C. Roth, F. Colucci, A. Cumano, and J. P. Di Santo. 2001. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31: 1900-1909.
12. Carotta, S., S. H. Pang, S. L. Nutt, and G. T. Belz. 2011. Identification of the earliest NK-cell precursor in the mouse BM. Blood 117: 5449-5452.
13. Fathman, J. W., D. Bhattacharya, M. A. Inlay, J. Seita, H. Karsunky, and I. L. Weissman. 2011. Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood 118: 5439-5447.
14. Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T. Walzer. 2009. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496.
15. Kim, S., K. Iizuka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3: 523-528.
16. Walzer, T., M. Bléry, J. Chaix, N. Fuseri, L. Chasson, S. H. Robbins, S. Jaeger, P. André, L. Gauthier, L. Daniel, et al. 2007. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA 104: 3384-3389.
17. Gonzaga, R., P. Matzinger, and A. Perez-Diez. 2011. Resident peritoneal NK cells. J. Immunol. 187: 6235-6242.
18. Veinotte, L. L., T. Y. Halim, and F. Takei. 2008. Unique subset of natural killer cells develops from progenitors in lymph node. Blood 111: 4201-4208.
19. Freud, A. G., and M. A. Caligiuri. 2006. Human natural killer cell development. Immunol. Rev. 214: 56-72.
20. Vosshenrich, C. A., M. E. García-Ojeda, S. I. Samson- Villéger, V. Pasqualetto, L. Enault, O. Richard-Le Goff, E. Corcuff, D. Guy-Grand, B. Rocha, A. Cumano, et al. 2006. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7: 1217-1224.
21. Di Santo, J. P., and C. A. Vosshenrich. 2006. Bone marrow versus thymic pathways of natural killer cell development. Immunol. Rev. 214: 35-46.
22. Schmitt, T. M., M. Ciofani, H. T. Petrie, and J. C. Zúñiga- Pflücker. 2004. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J. Exp. Med. 200: 469-479.
23. Porritt, H. E., L. L. Rumfelt, S. Tabrizifard, T. M. Schmitt, J. C. Zúñiga-Pflücker, and H. T. Petrie. 2004. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20: 735-745.
24. Schmitt, T. M., and J. C. Zúñiga-Pflücker. 2002. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17: 749-756.
25. Vargas, C. L., J. Poursine-Laurent, L. Yang, and W. M. Yokoyama. 2011. Development of thymic NK cells from double negative 1 thymocyte precursors. Blood 118: 3570-3578.
26. Hesslein, D. G., and L. L. Lanier. 2011. Transcriptional control of natural killer cell development and function. Adv. Immunol. 109: 45-85.
27. Yokota, Y., A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, and P. Gruss. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397: 702-706.
28. Boos, M. D., Y. Yokota, G. Eberl, and B. L. Kee. 2007. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204: 1119-1130.
29. Ramirez, K., K. J. Chandler, C. Spaulding, S. Zandi, M. Sigvardsson, B. J. Graves, and B. L. Kee. 2012. Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity 36: 921-932.
30. Gordon, S. M., J. Chaix, L. J. Rupp, J. Wu, S. Madera, J. C. Sun, T. Lindsten, and S. L. Reiner. 2012. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36: 55-67.
31. Samson, S. I., O. Richard, M. Tavian, T. Ranson, C. A. Vosshenrich, F. Colucci, J. Buer, F. Grosveld, I. Godin, and J. P. Di Santo. 2003. GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 19: 701-711.
32. Klein Wolterink, R. G., M. E. García-Ojeda, C. A. Vosshenrich, R. W. Hendriks, and J. P. Di Santo. 2010. The intrathymic crossroads of T and NK cell differentiation. Immunol. Rev. 238: 126-137.
33. Male, V., I. Nisoli, D. M. Gascoyne, and H. J. Brady. 2012. E4BP4: an unexpected player in the immune response. Trends Immunol. 33: 98-102.
34. Gascoyne, D. M., E. Long, H. Veiga-Fernandes, J. de Boer, O. Williams, B. Seddon, M. Coles, D. Kioussis, and H. J. Brady. 2009. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10: 1118-1124.
35. Kamizono, S., G. S. Duncan, M. G. Seidel, A. Morimoto, K. Hamada, G. Grosveld, K. Akashi, E. F. Lind, J. P. Haight, P. S. Ohashi, et al. 2009. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 206: 2977-2986.
36. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
37. Hu, Y., and G. K. Smyth. 2009. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347: 70-78.
38. Stewart, C. A., T. Walzer, S. H. Robbins, B. Malissen, E. Vivier, and I. Prinz. 2007. Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells. Eur. J. Immunol. 37: 1442-1452.
39. Takeda, K., E. Cretney, Y. Hayakawa, T. Ota, H. Akiba, K. Ogasawara, H. Yagita, K. Kinoshita, K. Okumura, and M. J. Smyth. 2005. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105: 2082-2089.
40. Huntington, N. D., S. L. Nutt, and S. Carotta. 2013. Regulation of murine natural killer cell commitment. Front. Immunol. 4: 14.
41. Luther, C., K. Warner, and F. Takei. 2011. Unique progenitors in mouse lymph node develop into CD127+ NK cells: thymus-dependent and thymus-independent pathways. Blood 117: 4012-4021.
42. Firth, M. A., S. Madera, A. M. Beaulieu, G. Gasteiger, E. F. Castillo, K. S. Schluns, M. Kubo, P. B. Rothman, E. Vivier, and J. C. Sun. 2013. Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J. Exp. Med. 210: 2981-2990.
43. Spits, H., and J. P. Di Santo. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12: 21-27.
44. Fuchs, A., W. Vermi, J. S. Lee, S. Lonardi, S. Gilfillan, R. D. Newberry, M. Cella, and M. Colonna. 2013. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-g-producing cells. Immunity 38: 769-781.
45. Seillet, C., N. D. Huntington, P. Gangatirkar, E. Axelsson, M. Minnich, H. J. M. Brady, M. Busslinger, M. J. Smyth, G. T. Belz, and S. Carotta. 2014. Differential requirement for Nfil3 during NK cell development. J. Immunol. 192: 2667-2676.